Search Results - "D'Erasmo, E."

Refine Results
  1. 1

    Bone damage in type 2 diabetes mellitus by Carnevale, V, Romagnoli, E, D'Erasmo, L, D'Erasmo, E

    “…Abstract This review focuses on the mechanisms determining bone fragility in patients with type 2 diabetes mellitus (T2DM). Despite bone mineral density (BMD)…”
    Get full text
    Journal Article
  2. 2

    Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol by Santori, C., Ceccanti, M., Diacinti, D., Attilia, M. L., Toppo, L., D’Erasmo, E., Romagnoli, E., Mascia, M. L., Cipriani, C., Prastaro, A., Carnevale, V., Minisola, S.

    Published in Journal of endocrinological investigation (01-04-2008)
    “…Background : Chronic alcohol abuse is a risk factor for osteoporosis and fractures, whose pathogenesis is still unclear. We investigated the influence of…”
    Get full text
    Journal Article
  3. 3

    Sporadic and hereditary primary hyperparathyroidism by Pepe, J, Cipriani, C, Pilotto, R, De Lucia, F, Castro, C, Lenge, L, Russo, S, Guarnieri, V, Scillitani, A, Carnevale, V, D'Erasmo, E, Romagnoli, E, Minisola, S

    Published in Journal of endocrinological investigation (01-07-2011)
    “…Primary hyperparathyroidism (PHPT) is a common endocrine disorder, particularly frequent in post-menopausal women. It is characterized by hypercalcemia with…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Hyperhomocysteinemia: a biochemical link between bone and cardiovascular system diseases? by Petramala, L, Acca, M, Francucci, C M, D'Erasmo, E

    “…Homocysteine (HCY) is a sulfur-containing amino acid involved in two metabolic pathways, catalized by cystathionine-B-synthase and methionine synthase,…”
    Get full text
    Journal Article
  6. 6

    Chronic constipation in hypercalcemic patients with primary hyperparathyroidism by Ragno, A, Pepe, J, Badiali, D, Minisola, S, Romagnoli, E, Severi, C, D'Erasmo, E

    “…Chronic constipation (C), among gastrointestinal symptoms, is commonly associated with primary hyperparathyroidism (PHPT) and probably attributable to…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism by LETIZIA, C, FERRARI, P, MAZZUOLI, G. F, COTESTA, D, CALIUMI, C, CIANCI, R, CERCI, S, PETRAMALA, L, CELI, M, MINISOLA, S, D'ERASMO, E

    Published in Journal of human hypertension (01-11-2005)
    “…The purpose of our study was to evaluate the behaviour of blood pressure (BP) by ambulatory monitoring of blood pressure (AMBP) in 53 patients with primary…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Cyclical changes of vertebral body heights and bone loss in healthy women after menopause by Mazzuoli, G., Diacinti, D., D'Erasmo, E., Alfò, M.

    Published in Bone (New York, N.Y.) (01-06-2006)
    “…Annual changes in vertebral body heights (VHs) and lumbar bone mineral density (LBMD) were evaluated in 120 healthy pre- and post-menopausal women aged 45–74…”
    Get full text
    Journal Article
  12. 12

    Metabolic bone diseases during long-term total parenteral nutrition by Acca, M, Ragno, A, Francucci, C M, D'Erasmo, E

    “…Long-term total parenteral nutrition (TPN) is a procedure commonly applied to patients with advanced forms of intestinal malabsorption. Among TPN…”
    Get full text
    Journal Article
  13. 13

    Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis by NUTI, R, BIANCHI, G, ORTOLANI, S, BRANDI, M. L, CAUDARELLA, R, D'ERASMO, E, FIORE, C, ISAIA, G. C, LUISETTO, G, MURATORE, M, ORIENTE, P

    Published in Rheumatology international (01-03-2006)
    “…In a randomized multicenter, double-blind, double-dummy, parallel group study a comparison of the efficacy and safety of 1 microg alfacalcidol to 880 IU…”
    Get full text
    Journal Article
  14. 14

    Type II benign osteopetrosis (Albers-Schönberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations by Letizia, C, Taranta, A, Migliaccio, S, Caliumi, C, Diacinti, D, Delfini, E, D'Erasmo, E, Iacobini, M, Roggini, M, Albagha, O M E, Ralston, S H, Teti, A

    Published in Calcified tissue international (01-01-2004)
    “…A 16-year-old male patient with type II autosomal dominant benign osteopetrosis (ADO) was genotyped and found to harbor a novel mutation in exon 25 of the gene…”
    Get full text
    Journal Article
  15. 15

    Expression of potassium channel isoforms mRNA in normal human adrenals and aldosterone-secreting adenomas by Sarzani, R, Pietrucci, F, Francioni, M, Salvi, F, Letizia, C, D'Erasmo, E, Dessì Fulgheri, P, Rappelli, A

    Published in Journal of endocrinological investigation (01-02-2006)
    “…Increased aldosterone secretion has been found in a mouse lacking the KCNE1 gene which codes for a regulatory protein of the KCNQ1 gene product, forming the…”
    Get full text
    Journal Article
  16. 16

    Biochemical markers in glucocorticoid-induced osteoporosis by Minisola, S, Del Fiacco, R, Piemonte, S, Iorio, M, Mascia, M L, Fidanza, F, Cipriani, C, Raso, I, Porfiri, M L, Francucci, C M, D'Erasmo, E, Romagnoli, E

    Published in Journal of endocrinological investigation (01-07-2008)
    “…Following the introduction of corticosteroids as therapeutic agents in the 1950s, their use has been expanded so that today glucocorticoids are widely used…”
    Get full text
    Journal Article
  17. 17

    Annual skeletal balance and metabolic bone marker changes in healthy early postmenopausal women: results of a prospective study by Mazzuoli, G., Acca, M., Pisani, D., Diacinti, D., Scarda, A., Scarnecchia, L., Pacitti, M.T., D’Erasmo, E., Minisola, S., Bianchi, G., Manfredi, G.

    Published in Bone (New York, N.Y.) (01-04-2000)
    “…The aim of this study was to establish the duration and annual rate of menopause-related bone loss and to investigate the relationship between bone turnover…”
    Get full text
    Journal Article Conference Proceeding
  18. 18

    Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone by Minisola, S, Dionisi, S, Pacitti, M T, Paglia, F, Carnevale, V, Scillitani, A, Mazzaferro, S, De, Geronimo S, Pepe, J, Derasmo, E, Romagnoli, E

    Published in Osteoporosis international (01-01-2002)
    “…To assess how two different serum markers of bone resorption may reflect changes in bone turnover, we compared age- and sex-related changes in serum C-terminal…”
    Get full text
    Journal Article
  19. 19

    Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease by Vizza, C.D., Letizia, C., Sciomer, S., Naeije, R., Della Rocca, G., Di Roma, A., Musarò, S., Quattrucci, S., Gaudio, C., Battagliese, A., Badagliacca, R., D'Erasmo, E., Fedele, F.

    Published in Regulatory peptides (15-01-2005)
    “…To study adrenomedullin (AM) plasma levels in patients with severe lung disease and to analyze the relationship between AM and heart changes, hemodynamics and…”
    Get full text
    Journal Article
  20. 20

    Calcium homeostasis during oral glucose load in healthy women by D'Erasmo, E, Pisani, D, Ragno, A, Raejntroph, N, Vecci, E, Acca, M

    Published in Hormone and metabolic research (01-04-1999)
    “…It has been demonstrated that in healthy subjects during oral glucose tolerance test, serum calcium declines, while urinary calcium excretion increases, even…”
    Get more information
    Journal Article